Persistence of Sulfadoxine-Pyrimethamine Resistance Despite Reduction of Drug Pressure in Malawi-Reference-Cited by-同舟云学术

Persistence of Sulfadoxine-Pyrimethamine Resistance Despite Reduction of Drug Pressure in Malawi

Published:2015-02-11 Issue:5 Volume:212 Page:694-701
ISSN:0022-1899
Container-title:Journal of Infectious Diseases
language:en
Short-container-title:J Infect Dis.

Author:

Artimovich Elena,Schneider Kristan,Taylor Terrie E.,Kublin James G.,Dzinjalamala Fraction K.,Escalante Ananias A.,Plowe Christopher V.,Laufer Miriam K.,Takala-Harrison Shannon

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/212/5/694/13806791/jiv078.pdf

Reference34 articles.

1. Return of Chloroquine Antimalarial Efficacy in Malawi

2. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum

3. Return of Chloroquine‐Susceptible Falciparum Malaria in Malawi Was a Reexpansion of Diverse Susceptible Parasites

4. Molecular Markers for Failure of Sulfadoxine‐Pyrimethamine and Chlorproguanil‐Dapsone Treatment ofPlasmodium falciparumMalaria

5. Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Seasonal malaria chemoprevention and the spread of Plasmodium falciparum quintuple-mutant parasites resistant to sulfadoxine–pyrimethamine: a modelling study;The Lancet Microbe;2024-09

2. Seasonal malaria chemoprevention and the spread ofPlasmodium falciparumquintuple mutant parasites resistant to sulfadoxine-pyrimethamine: a modelling study;2023-07-24

3. Understanding the Intransigence of Malaria in Malawi;The American Journal of Tropical Medicine and Hygiene;2022-10-11

4. Spatiotemporal spread of Plasmodium falciparum mutations for resistance to sulfadoxine-pyrimethamine across Africa, 1990–2020;PLOS Computational Biology;2022-08-11

5. High burden of malaria among Malawian adults on antiretroviral therapy after discontinuing prophylaxis;AIDS;2022-07-15